Nanoparticles in sputum - a new window to airway inflammation

A. Bar-Shai (Tel-Aviv, Israel)

Source: International Congress 2017 – Systemic and airway biomarkers
Session: Systemic and airway biomarkers
Session type: Thematic Poster
Number: 1008
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bar-Shai (Tel-Aviv, Israel). Nanoparticles in sputum - a new window to airway inflammation. 1008

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical applications of assessment of airway inflammation using induced sputum
Source: Eur Respir J 2002; 20: 40S-43S
Year: 2002


Disconnect between sputum neutrophils and other measures of airway inflammation in asthma
Source: Eur Respir J 2014; 43: 627-629
Year: 2013


Induced sputum and airway inflammation in asthma and COPD
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006

Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study
Source: Eur Respir J 2010; 35: 48-53
Year: 2010



Late Breaking Abstract - A GATA3-specific DNAzyme attenuates sputum eosinophilia in COPD patients with eosinophilic airway inflammation
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017

Increasing sputum basophils is a marker for eosinophil-dominant airway inflammation in adult asthma
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018

The new paradigm: assessing airway inflammation rather than diagnostic labelling is a movement not a fad
Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease
Year: 2006


Neutrophils in bronchial mucosa, sputum and blood after administration of the CXCR2-antagonist AZD5069 - An explorative study in neutrophilic asthma
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016

Mucosal cryobiopsies – a new method for studying airway pathology in asthma
Source: Virtual Congress 2021 – Bronchoscopy in the COVID - 19 era: cryobiopsy
Year: 2021


Galectn-3 : marker of airway inflammation in bronchial asthma
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018


Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma
Source: Eur Respir J 2001; 18: 444-450
Year: 2001



Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms
Source: Eur Respir J 2008; 31: 396-406
Year: 2008



Extracellular purines are biomarkers of neutrophilic airway inflammation
Source: Eur Respir J 2008; 31: 949-956
Year: 2008



Chronic sputum production in COPD is a marker for airway inflammation and colonisation
Source: Eur Respir J 2004; 24: Suppl. 48, 306s
Year: 2004

Novel concepts in airway inflammation and remodelling in asthma
Source: Eur Respir J 2015; 46: 1796-1804
Year: 2015



Roles of bronchoscopy and noninvasive measurements of airway inflammation in evaluating chronic cough: the role of noninvasive measurements of airway inflammation
Source: Annual Congress 2007 - PG23 - Managing chronic cough: guidelines and controversies (jointly organised with ACCP)
Year: 2007



Airway inflammation: assessment of neutrophil apoptosis in induced sputum
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005


Outgrown asthma does not mean no airways inflammation
Source: Eur Respir J 2002; 19: 284-287
Year: 2002